NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.



Don't have an account? Register

ADVERTISEMENT

ADVERTISEMENT

Lack of staff for systemic therapy programme classed as ‘risk’ — NCCP

By Mindo - 18th Nov 2019

The lack of staffing for the systemic therapy programme presents a risk to implementing a new model of care in the area, according to the National Cancer Control Programme (NCCP).

A meeting of the NCCP’s executive management team in March heard that additional manpower resources are required for the systemic therapy programme to carry out its work.

The minutes of the meeting, obtained by the Medical Independent (MI) through Freedom of Information law, state with reduced staffing, “the programme will focus on areas in relation to Brexit and NCIS [National Cancer Information System] go-live”.

 The meeting heard how the NCIS was due to start running in May.

The system is designed to ensure optimal and safe delivery of systemic cancer treatment, including e-prescribing and e-administration of chemotherapy, for the treatment of cancer, in publicly-funded hospitals.

“It was agreed that lack of STP [systemic therapy programme] resources will impact on the model of care project and agreed that it should be added to NCCP risk register,” according to the minutes.

Minutes of the May meeting state no additional resources were allocated in the HSE Service Plan 2019 to support the systemic therapy programme project requirements in terms of cancer strategy recommendations.

These resources have been sought again for 2020, according to the minutes.

“Indicative figures at present show €4.5 million available to resource NCCP new developments across the whole of the country and for all programmes within the National Cancer Strategy 2017-2026,” a spokesperson for the NCCP told MI.

Additional resources for systemic therapy released in the latter half of 2019 are: Pharmacy posts related to Brexit in order to facilitate a quality assurance programme; support for the systemic therapy programme to “build resilience” across the hospitals providing systemic therapy; and some additional equipment costs.

Leave a Reply

ADVERTISEMENT

Latest

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

Latest Issue
MI2024-07-23
Medical Independent 23rd July 2024

You need to be logged in to access this content. Please login or sign up using the links below.

ADVERTISEMENT

Trending Articles

ADVERTISEMENT